CARB-X Announces 2018 Round Of Funding For Antibacterial Research

23/02/2018 William New

CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading ->

New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease

07/02/2018 William New

A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading ->

Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty

05/02/2018 William New

Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading ->

05/02/2018 Catherine Saez

The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines. Continue reading ->

FIND Announces Four New Collaborations To Address AMR

31/01/2018 Catherine Saez

The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR). Continue reading ->

Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives

18/01/2018 Catherine Saez

An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies. Continue reading ->

Medicines Patent Pool Expands Its Patent Database To Cancer Treatments

12/12/2017 Catherine Saez

The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications. Continue reading ->

Industry Urges UK, EU, To Safeguard Medicines Regulation During Post-Brexit Transition

28/11/2017 William New

Associations representing the life sciences industry in the United Kingdom and Europe today issued a call for cooperation on regulation between the UK and European Union on medicines regulation. Continue reading ->

WHO Draft Work Program To Be Presented, Discussed

21/11/2017 Catherine Saez

The World Health Organization is presenting its draft work program for 2019-2023 for consideration by member states this week. Continue reading ->

Brexit Drives European Medicines Agency To The Netherlands, Move By March 2019

21/11/2017 Catherine Saez

As a consequence of the decision of the United Kingdom to go its separate way, the remaining European Union member states decided yesterday that the European Medicines Agency should move to Amsterdam by the end of March 2019. Continue reading ->